R
Redhill Biopharma Ltd
RDHL
0.75130
USD
0.3705
(97.30%)
مغلق
حجم التداول
204
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
10,615,668
العنوان: Redhill Biopharma Ltd
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.